Keywords: cenomed/torreypines, licensing, deal, cenomed, biosciences, majority-owned, subsidiary

Cenomed/TorreyPines in licensing deal

Article | 13 October 2008

Cenomed BioSciences, a majority-owned subsidiary of Abraxis BioScience, and TorreyPines Therapeutics have entered into an exclusive licensing agreement whereby the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Abraxis

Go to company listing